Skip to content

What is the ED95 dose for bupivacaine for supraclavicular brachial plexus block using ultrasound? - ED95 bupivacaine and supraclavicular block

What is the ED95 dose for bupivacaine for supraclavicular brachial plexus block using ultrasound? - ED95 bupivacaine and supraclavicular block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-011829-13-GB
Enrollment
Unknown
Registered
2010-07-15
Start date
2009-11-02
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients presenting for routine upper limb surgery

Interventions

Trade Name: Marcain Polyamp Steripack 0.5% Product Name: Marcain Polyamp Steripack 0.5% Pharmaceutical Form: Injection* INN or Proposed INN: bupivacaine hydrochloride Concentration unit: % (W/V) perce

Sponsors

University of Leeds
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria • ASA 1-3 patients • Age > 18 years • Routine hand, forarm or upper limb surgery • Patients of either sex Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Exclusion Criteria • ASA > 3 • Age 35 . Pregnant woman

Design outcomes

Primary

MeasureTime frame
Main Objective: What is the ED95 dose of 0.5% bupivacaine for supraclavicular brachial plexus nerve block using ultrasound?;Secondary Objective: None;Primary end point(s): Assessment of effect of block to cold with alcohol swab in the distribution of ulnar, median, radial and musculocutaneous nerves in upper arm every 15 minutes for 45 minutes. The trial will conclude at 45 minutes after the injection.

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026